Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis

V Kouranos, GE Tzelepis, A Rapti, S Mavrogeni… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives : The goal of this study was to assess the independent and collective diagnostic
value of various modalities in cardiac sarcoidosis, delineate the role of cardiac magnetic …

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised …

…, GA Margaritopoulos, M Kokosi, V Kouranos… - The Lancet …, 2018 - thelancet.com
Background In fibrotic interstitial lung diseases, exertional breathlessness is strongly linked
to health-related quality of life (HRQOL). Breathlessness is often associated with oxygen …

The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions

…, SR Desai, J Barnett, V Kouranos… - The Lancet …, 2020 - thelancet.com
1 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. Lancet 2020; 395: 497–506. 2 Yin Y, Wunderink RG. MERS, SARS …

BTS Clinical Statement on pulmonary sarcoidosis

…, CP Atkins, A Crawshaw, SP Hart, LP Ho, V Kouranos… - Thorax, 2021 - thorax.bmj.com
This British Thoracic Society (BTS) Clinical Statement addresses the diagnosis, evaluation
and management of pulmonary sarcoidosis, with each section summarised with key clinical …

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study

…, M Kokosi, Y Kondoh, V Kouranos… - European …, 2017 - Eur Respiratory Soc
We conducted an international study of idiopathic pulmonary fibrosis (IPF) diagnosis among
a large group of physicians and compared their diagnostic performance to a panel of IPF …

Cardiac sarcoidosis: state-of-the-art review

V Kouranos, R Sharma - Heart, 2021 - heart.bmj.com
Sarcoidosis is a systemic inflammatory disease characterised histologically by the formation
of non-caseating granuloma in multiple organs. 1 The cause of the disease remains …

Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: a Bayesian retrospective observational cohort study

…, T Semple, W Li, PM George, V Kouranos… - …, 2023 - Wiley Online Library
Background and Objective Pulmonary hypertension is a life‐limiting complication of interstitial
lung disease (ILD‐PH). We investigated whether treatment with phosphodiesterase 5 …

Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact

…, C La Vecchia, F Chua, V Kouranos… - European …, 2020 - Eur Respiratory Soc
Interstitial lung disease (ILD) in systemic sclerosis (SSc) is a major cause of morbidity and
mortality, mostly presenting as non-specific interstitial pneumonia. Little is known about the …

[HTML][HTML] Fibrotic hypersensitivity pneumonitis: key issues in diagnosis and management

V Kouranos, J Jacob, A Nicholson… - Journal of clinical medicine, 2017 - mdpi.com
The diagnosis of hypersensitivity pneumonitis (HP) relies on the clinical evaluation of a
number of features, including a history of significant exposure to potentially causative antigens, …

Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and clinical features

V Kouranos, S Ward, MA Kokosi, D Castillo, F Chua… - Chest, 2020 - Elsevier
Background In cohort studies of pulmonary sarcoidosis, abnormal ventilatory patterns have
generally been subdivided into restrictive and obstructive defects. Mixed ventilatory defects …